Upload
gerhard-friedrich
View
213
Download
1
Embed Size (px)
Citation preview
Determination of Testosterone Metabolitesin Rat Hepatocytes with and withoutCryopreservation by On-Line SPEColumn-Switching LC and MS Detection
Gerhard Friedrich1,&, Thorsten Rose1, Alexander Wawkuschewski1, Sabine Kafert-Kasting2,Britta Laube2, Lubomir Arseniev2, Klaus Rissler3
1 Pharmbiodyn, Institute of Contract Research, P. O. Box 1108, 79207 Denzlingen, Germany; E-Mail: [email protected] Cytonet GmbH & Co. KG Hannover Branch, Feodor Lynen Strasse 21, 30625 Hannover, Germany3 Brunnlirain 5, 4125 Riehen, Switzerland
Received: 21 May 2007 / Revised: 8 November 2007 / Accepted: 8 November 2007Online publication: 12 December 2007
Abstract
In a recently published paper development of a sensitive automated ‘‘on-line’’ solid-phase extraction (SPE)/RP-HPLC assay for 6b-hy-droxytestosterone (6b-OHT) with corticosterone as the internal standard (IS) was reported and its potential for quantification of varioustestosterone metabolites in culture media reflecting metabolic activity of cultured human and animal hepatocytes demonstrated [1]. In thisfollowing contribution the technique has been extended to determination of another five testosterone metabolites in cultured rat hepatocytesusing an identical ‘‘on-line’’ SPE/RP-HPLC procedure and detection by tandem MS-MS with an atmospheric pressure chemical ionization(APCI) source in the selected reaction monitoring (SRM) mode as that described in [1]. All six testosterone metabolites, namely 2a-OHT,2b-OHT, 6a-OHT, 6b-OHT, 7a-OHT and 16a-OHT, could be sufficiently separated from each other and thus an unequivocal assignment tothe individual structures was achieved. Validation data are presented specifying the limits of quantitation as well as the mean values of thecoefficients of variation (CV) for the target analytes and the accuracy obtained at five different days. Regio- and stereoselective testosteronehydroxylation by rat hepatocytes was measured in a long-term culture system with and without exposure to rifampicin as an inducer of liverCYP 3A4 activity. In addition, testosterone hydroxylation was analyzed in cultures of cryopreserved hepatocytes that had been stored at�196 �C. The rat hepatocytes were cultured after thawing for up to 11 days and induction of testosterone hydroxylase activity could bedemonstrated in cultures which underwent a new cryopreservation protocol.
Keywords
Column liquid chromatographyOn-line SPE/LC-MSTestosterone metabolitesHydroxylase activitiesHepatocytes
Introduction
Cytochrome P 450 (CYP) isoenzymes,
which all are members of the haemo-
protein family, play an essential role in
biotransformation of either drugs or
endogenous substrates [2–21]. Testoster-
one is one of the most important
endogenous targets for the action of liver
enzymes, undergoing various pathways
of biotransformation, which in the case
of cytochrome oxidase P 450 3A4 (CYP
3A4) preponderantly yields 6b-hydroxy-This paper is dedicated to Professor HinrichCramer on the occasion of his 75th birthday.
2008, 67, 31–39
DOI: 10.1365/s10337-007-0485-20009-5893/08/01 � 2007 Friedr. Vieweg & Sohn Verlag/GWV Fachverlage GmbH
Original Chromatographia 2008, 67, January (No. 1/2) 31
testosterone (6b-OHT) as the main
metabolite [13, 14, 16, 18]. In the same
way 6b-OHT also represents the main
testosterone metabolite in hepatic micro-
somes of untreated rats accounting for
about two thirds of total metabolites [14].
‘‘In vitro’’ studies using mammalian
hepatocytes are generally considered as
a valuable tool for prediction of in vivo
metabolism with special focus on the
prediction of xenobiotic biotransforma-
tion patterns in the liver. When relying
on cell culture systems for the analysis
of unknown biotransformation path-
ways, e.g., of a drug candidate molecule,
it is important to assure the metabolic
competence of the hepatocytes in cul-
ture by measuring reference metabolic
activities. In this respect, testosterone
metabolism is frequently used to assess
CYP 3A4 activity by analysis of
6b-OHT generation. CYP 3A4, which
alone comprises an average of 70% of
the total intestinal CYP content [2], is
of special interest since a majority of
xenobiotics is converted by this enzyme
complex.
Another important feature concern-
ing the quality of in vitro hepatocyte sys-
tems is the inducibility of enzyme
activities. CYP isoenzymes are inducedby
a variety of compoundswidely differing in
structural features. In this respect, phe-
nobarbital [12], 3-methylcholanthrene
and Aroclor 1254 [13], the latter com-
posed of a mixture of chlorinated biphe-
nyls, as well as rifampicin [14] are widely
chosen as the standard inducers of
CYP 3A4 activity. However, important
species differences are known to exist
as studied by Kern et al. who also found
a substantial effect of rifampicin on
6b-testosterone hydroxylase activity in
cultured human hepatocytes, whereas
no effect was reported in rat hepato-
cytes [14].
Besides 6b-OHT, a number of posi-
tional isomers are generated from tes-
tosterone by action of CYP isoenzymes
different form CYP 3A4. In this respect,
CYP 2C11 was shown to produce
7a-OHT [23, 24], 16b-OHT [23, 24],
16a-OHT [17, 23] and 2a-OHT [17,
21–24] the latter activity also generated
by CYP 3A2 [17], CYP 1A1 and CYP
3A1 [22, 23]. Although CYP 3A4 still
represents the main pathway of 6b-OHT
formation, a wide variety of other CYP
isoenzymes, such as, e.g., CYP 1A1, [22],
CYP 1A2 [22], CYP 3A1 [9, 14, 17,
21–24], CYP 3A2 [9, 17, 24], CYP 2A2
[17], CYP 2C13 [17] as well as CYP 3A3
and CYP 3A5 [18] contribute to
6b-hydroxylation. CYP 1A1 [22], CYP
2A1 [17, 18, 22–24], CYP 2A2 [17] and
CYP 2B1/2 [23, 24] are responsible for
oxidization of testosterone to 7a-OHT
and, in addition, CYP 2A2 also yields
12b-OHT [18], 15a-OHT [17] and
18-OHT [17]. Besides 6b-OHT, 2b-OHT
and 15b-OHT were generated by action
of CYP 3A1 [17, 21, 23, 24] and CYP
3A2 [23, 24], whereas CYP 2A4/5
participates in 15b-hydroxylation [24]. In
addition to the action of CYP 2C11
[17, 22–24], hydroxylation of testoster-
one to 16a-OHT is also catalyzed by
CYP 2B1 [17, 18, 21, 23, 24] and CYP
2B2 [21, 23, 24]. Interestingly CYP
2B1 [21, 23] and CYP 2B2 [21, 23, 24]
also participate in 16b-OHT formation
[17, 18, 21, 23].
A compilation of hitherto used
chromatographic procedures for either
identification or quantitative determi-
nation of a variety of testosterone
metabolites is given in [1] and the
reader is referred to this paper to get
more comprehensive information. In the
same paper development of a highly
specific ‘‘on-line’’ SPE/column-switch-
ing gradient reversed-phase HPLC as-
say for determination of 6b-OHT in
media mimicking the situation in cul-
tured human hepatocytes is reported.
In this contribution the method is
extended to quantitative determination
of another five testosterone metabolites
from cultured rat hepatocytes. As
already successfully applied previously,
both exact structural assignment and
quantitative determination was done by
tandem LC-MS-MS in the selected
reaction monitoring (SRM) mode. In
this respect 2a-, 2b-, 6a-, 6b-, 7a- and
16a-OHT using corticosterone as the
internal standard (IS), were detected and
quantified. The method was applied to
quantitation of these testosterone
metabolites in rat hepatocytes. The
hepatocyte cultures were characterized
over time, with and without rifampicin
induction, and with and without cryo-
preservation.
Experimental
Reagents and Materials
The testosterone metabolites 2a-OHT,
2b-OHT, 6a-OHT, 6b-OHT, 16a-OHT
and corticosterone as the IS were ob-
tained from Sigma-Aldrich (Steinheim,
Germany), whereas 7a-OHT was re-
ceived from Ultrafine Chemicals
(Manchester, UK). Methanol and
2-propanol (both gradient grade) and
formic acid (analytical grade) were
purchased from Merck (Darmstadt,
Germany) and triethylamine (puriss,
p. a.) from Fluka (Buchs, Switzerland).
DMSO for medical purpose was from
WAK Chemie (Steinbach, Germany).
For cell culturing experiments fetal calf
serum from Biochrom (Berlin,
Germany) and HepatoZym from Gibco
(Eggenstein, Germany) were used. Dul-
becco’s modified eagle medium (DMEM
High Glucose) was obtained from
Cell Concepts (Umkirch, Germany).
The mixture of b-glucuronidase and
arylsulfatase was from Roche Diagnos-
tics (Mannheim, Germany) and rifam-
picin from Sigma-Aldrich (Steinheim,
Germany). High purity water for the use
in HPLC was prepared with a Milli-Q
reagent water systemTM from Millipore-
Waters (Milford, MA, USA). A BioTrap
500 MSTMSPE-column (20 · 4 mmI.D.)
from Chromtech (Hagersten, Sweden)
and a Prontosil 60-5 C18-H (250 · 2 mm
I. D., 5 lm particle size) analytical
column from Bischoff (Leonberg,
Germany), were used for sample extrac-
tion and separation, respectively.
Preparation of Hepatocytesand Sample Generation fromCell Culture Supernatants
Hepatocytes were prepared and cultured
at Cytonet GmbH & Co. KG, branch
Hannover. The rat hepatocytes were
isolated from male Wistar WKY rats as
described by Hengstler et al. [25]. Cryo-
preservation was performed following
the protocol published earlier [26]. For
induction experiments, the cells were
cultured in the presence of 50 lMrifampicin for 24 h prior to the testos-
32 Chromatographia 2008, 67, January (No. 1/2) Original
terone hydroxylation assay performed at
day 3 and 8, respectively. Prior to addi-
tion of testosterone, the cultures were
washed once with serum free medium
and subsequently incubated for one hour
in the presence of 250 lM testosterone.
After 60 min aliquots of 800 lL of the
cell culture supernatant were removed
and hydrolysed with 100 Fishman units
of b-glucuronidase and 800 Roy units of
arylsulfatase at pH 4.5 for 2 h at 37 �Cwith agitation. The samples were then
shock-frozen in liquid nitrogen and
stored at �80 �C.The concentration C (ng mL�1) of
the respective monohydroxy-testosterone
(OHT) species was determined byHPLC-
MS-MS as described below and the
hydroxylation activities (pMol min�1)
were calculated as follows: activity =
C · V · f/t · M, taking into account
the molecular mass (M = g mol�1) of
OHT, the incubation time (t = 60 min),
the volume of the cell culture superna-
tant (V = 1 mL) and an experimental
factor resulting from supernatant dilu-
tion during hydrolyzation (f = 1.1335).
The calculation of testosterone hydrox-
ylation activity refers to all viable cells in
the well from which the supernatant was
derived.
Sample Preparation,Chromatographic Separationand Detection
For preparation of calibration samples,
IS and quality controls as well as
extraction of the target analytes from the
biological matrices using a column-
switching device, the same protocol as
that described previously [1] was applied.
In brief, a solution of the IS corticoste-
rone (1 mg mL�1) was dissolved in
methanol/water 1:1 (v,v) and diluted to
20 lg mL�1 with DMEM High Glucose.
The different testosterone metabolites
were prepared in a corresponding way to
yield final dilutions of 30, 50, 100, 250,
500, 1000, 2000, 4000 ng mL�1 for the
calibratorsand250, 500and1000 ng mL�1
for the quality controls, except for
7a-OHT, where the ranges for calibra-
tion and controls were 5, 15, 30, 50, 100,
250, 500, 1000 ng mL�1 and 5, 15, 30, 50
and 100 ng mL�1, respectively. Prior to
sample preparation 50 lL of IS
(20 lg mL�1) was added to 500 lL of
calibration solutions, quality controls
and supernatants of cultured rat hepa-
tocytes from which 100 lL were
subjected to the ‘‘on-line’’ SPE/column-
switching RP-HPLC procedure. Analyte
enrichment by means of a BioTrap
500 MSTM SPE column was carried
out with 10 mM triethylammonium
formate buffer (pH 6). Back-flush of
analyte onto the analytical C18 column
and subsequent chromatographic sepa-
ration was accomplished in the gradi-
ent mode with mobile phase A composed
of water–methanol–tetrahydrofuran
(73:20:7, v/v/v) and mobile phase B
composed of methanol and THF
(93:7, v/v) at a flow-rate of 0.2 mL
min�1. Signal monitoring was effected by
tandem MS-MS detection in the SRM
mode. The individual experimental con-
ditions of the column-switching protocol
comprising pre-column sample extrac-
tion, back-flush onto the analytical col-
umn, final chromatographic separation
0 5 10 15 20 25 30 35
Time (min)
0
1
2
3
4
5
6
7
8
9
10
0
1
2
3
4
5
6
7
8
9
10
7
2
1
6
4
3
5
Fig. 1. HPLC-MS (SRM) chromatograms of the monohydroxy testosterone metabolites1 = 2a-OHT, 2 = 2b-OHT, 3 = 6a-OHT, 4 = 6b-OHT, 5 = 7a-OHT, 6 = 16a-OHT onthe upper trace and and 7 = the internal standard corticosterone on the lower trace
Original Chromatographia 2008, 67, January (No. 1/2) 33
in the gradient mode and mass spectro-
metric detection are completely identical
to those reported previously [1].
Results
Sample Extraction,Chromatographic Separationand Detection
Using the chromatographic procedure
described previously [1], all members of
a standard mixture of the six analytes to
be determined as well as the IS cortico-
sterone were sufficiently separated from
each other (Fig. 1) and assignment of the
HPLC signals could be unambiguously
effected by means of their characteristic
retention times under the applied exper-
imental conditions. However, it should
be mentioned that the pairs 7a-/15a-OHT, 2b-/11b-OHT and 6b-/19-OHT
cannot be separated from each other
using the applied chromatographic
system. Nevertheless, as shown in our
research group (unpublished observa-
tions), at least partial separation of all
these critical pairs can be accomplished
when switching to a more shallow gradi-
ent profile and a substantial increase
in run time. However, induction of
15b-OHT, 11b-OHT and 19-OHT does
not play a significant role after CYPP 450
enzyme induction of hepatocytes ob-
tained from the investigated species
[20–22]. As a consequence, chromatog-
raphy described in [1] effecting satisfac-
tory separation of the six target hydroxy
Table 1. Precision and accuracy data of 2a-OHT (a), 2b-OHT (b), 6a-OHT (c), 6b-OHT (d), 7a-OHT (e) and 16a-OHT (f)
270602 010902 021002 241002 021202Calc. amount(ng mL�1)
Calc. amount(ng mL�1)
Calc. amount(ng mL�1)
Calc. amount(ng mL�1)
Calc. amount(ng mL�1)
Mean SD CV (%) Acc. (%)
a: Validation data of 2a-OHT250 161.9 254.5 250.9 235.9 244.8 241.9 33.6 13.9 96.8250 293.5 257.6 248.8 250.0 221.2 254.2 25.9 10.2 101.7500 442.6 316.8 446.8 475.4 512.2 458.3 67.7 14.8 91.7500 n. d. 460.2 429.8 472.7 568.0 482.7 59.7 12.4 96.51000 970.2 1020.6 1172.5 816.4 979.1 1047.8 120.6 11.5 104.81000 1056.4 1093.3 1191.5 1199.0 979.1 1103.9 93.1 8.4 110.4
b: Validation data of 2b-OHT250 188.0 239.4 252.5 226.5 253.6 238.3 20.8 8.7 95.3250 248.8 251.3 247.9 251.9 223.2 244.6 12.1 4.9 97.9500 307.0 320.4 436.2 492.1 544.6 451.2 87.2 19.3 90.2500 432.2 462.1 457.6 470.9 589.1 482.4 61.4 12.7 96.51000 1043.0 955.3 1137.3 844.3 1016.5 1037.1 99.8 9.6 103.71000 1046.4 1102.0 1107.4 1171.3 947.7 1075.0 83.8 7.8 107.5
c: Validation data of 6a-OHT250 286.6 223.8 284.7 319.6 273.1 271.7 37.5 13.8 108.7250 243.4 224.8 276.1 336.0 249.3 265.9 43.3 16.3 106.4500 462.2 539.5 522.5 576.0 472.1 490.4 63.6 13.0 98.1500 416.7 393.6 460.5 583.4 477.2 466.3 73.5 15.8 93.31000 956.2 950.7 1189.9 1170.7 991.2 1060.0 100.7 9.5 106.01000 1044.6 948.5 1027.6 1181.0 1140.0 1068.3 92.8 8.7 106.8
d: Validation data of 6b-OHT250 219.7 230.6 256.2 264.9 282.0 250.3 21.1 8.4 100.1250 279.7 233.0 254.4 248.1 234.5 250.0 18.9 7.6 100.0500 404.4 551.5 482.2 523.5 520.3 491.7 52.1 10.6 98.3500 492.5 413.8 463.5 555.7 509.6 487.0 52.8 10.8 97.41000 1152.8 979.2 1090.3 960.1 1111.0 1056.1 63.1 6.0 105.61000 1104.9 1005.1 1019.4 1052.5 1085.3 1053.4 42.3 4.0 105.3
e: Validation data of 7a-OHT5 5.2 5.0 5.3 5.2 4.6 5.0 0.3 5.3 101.015 13.9 – 12.2 12.1 16.7 13.7 2.1 15.6 91.530 26.5 35.6 35.5 32.9 30.5 32.2 3.8 11.9 107.350 58.0 44.4 56.6 56.0 46.6 52.3 6.3 12.0 104.6100 95.2 93.8 97.2 118.1 95.6 100.0 10.2 10.2 100.0
f: Validation data of 16a-OHT250 222.7 227.0 241.7 284.1 274.3 253.4 22.1 8.7 101.3250 261.7 266.4 226.4 267.7 261.5 256.7 17.2 6.7 102.7500 395.3 487.8 440.1 524.8 537.1 485.2 53.1 10.9 97.0500 469.1 437.0 466.1 537.5 557.7 493.5 51.5 10.4 98.71000 1024.1 1005.8 987.2 955.6 1105.0 1023.9 48.4 4.7 102.41000 1056.2 1028.9 964.8 1026.9 1084.1 1032.2 44.3 4.3 103.2
ND not determined
34 Chromatographia 2008, 67, January (No. 1/2) Original
testosterone metabolites was not changed
and sensitive quantitative determination
of the six testosterone metabolites was
achieved by mass spectroscopy in the
SRM mode exploiting the transitions
m/z 305.3 (267.7–270.7) for all testos-
terone monohydroxy metabolites and
m/z 347.1 (327.7–330.7) for the IS
corticosterone [1].
Linearity, Specificity, Precisionand Accuracy, Limitof Detection
An exhaustive validation protocol for
6b-OHT has been published in [1] and
therefore, only a short one is given here.
As in the case of 6b-OHT [1], linearity
was achieved in the concentration range
of 100–4000 ng mL�1 for 2a-OHT,
2b-OHT, 6a-OHT, 6b-OHT and
16a-OHT using a total of eight calibra-
tors as well as 5–1000 ng mL�1 for of
7a-OHT (for individual concentrations
see ‘‘Experimental’’). In all cases the
mean values for the correlation factor r2
were >0.99 (mean = 0.9985). As de-
picted in Table 1a–f, mean values of the
coefficients of variation (% CV) for the
target analyte obtained for the concen-
trations 250, 500 and 1000 ng mL�1 at
five different days over a period of
5 months ranged from 8.4–14.8% for
2a-OHT, 4.9–19.3% for 2b-OHT,
8.7–16.3% for 6a-OHT, 4.0–10.8% for
6b-OHT and 4.3–10.9% for 16a-OHT.
The corresponding values for the accu-
racy were 91.7–110.4% for 2a-OHT,
90.2–107.5% for 2b-OHT, 93.3–108.7%
for 6a-OHT, 97.4–105.6% for 6b-OHT
and 97.0–103.2% for 16a-OHT. In the
case of 7a-OHT, where substantially
lower concentrations are encountered
compared with the other metabolites un-
der investigation, control measurements
have been performed at the 5, 15, 30, 50
and 100 ng mL�1 level. The mean values
for either%CV and accuracy as shown in
Table 1e ranged from 5.3–15.6% and
91.5–107.3%, respectively. If concentra-
tions of metabolites are expected to be
very low, higher sample volumes are to be
subjected to the SPE procedure. In this
way using 1000 lL of sample the limits of
quantitation can be decreased to 1.0, 0.7,
0.4, 2.0, 0.5 and 1.5 ng, respectively for
2a-OHT, 2b-OHT, 6a-OHT, 6b-OHT,
7a-OHT and 16a-OHT.
Testosterone HydroxyMetabolites Determinedin Supernatants from RatHepatocyte Cultures
One representative chromatogram show-
ing the metabolic profile attributable to
rat hepatocytes is depicted in Fig. 2.
As shown in Fig. 3, memory effects
during long term chromatography are
avoided using the tandem approach
technique, i. e., column A and column B
in change, which proved to be the case in
thousands of runs.
Quantitative analysis was performed
with samples generated at culture days 0,
1, 3 and 8 for rat hepatocytes with and
without cryopreservation. Please note
that culture day 0 means the day of cell
isolation for the cell cultures not under-
going cryopreservation and the day of
thawing for the cryopreserved cultures.
For the cell preparation shown, at day 0
the cryopreserved cultures displayed
elevated enzyme activities as compared
to the freshly prepared hepatocytes (see
Fig. 3). This phenomenon was observed
0 5 10 15 20 25 30 35 40
Time (min)
0
1
2
3
4
5
6
7
8
9
10
0
1
2
3
4
5
6
7
8
9
10
8
3
5
4 6
9
1
2
7
Fig. 2. Representative chromatogram of testosterone metabolites obtained from rat hepatocytesafter induction with rifampicin; peaks 8 and 9 are attributable to hitherto unknownmonohydroxy testosterone metabolites; peak numbering 1–7 as in Fig. 1
Original Chromatographia 2008, 67, January (No. 1/2) 35
in about 50% of the cultures analyzed.
Meanwhile, activities of cultures with
and without cryopreservation were
comparable at day 1 and day 3 and
depression of enzyme activity in the
cryopreserved cultures was observed at
day 8 for 6b-OHT, 16a-OHT, 2a-OHT
and 2b-OHT. While the maximum cul-
ture time after thawing was 11 days for
one specific cell preparation, data ob-
tained 8 days after thawing were reliably
achieved (data not shown).
In addition to the basal levels of en-
zyme activity, the inducibility of a given
enzyme activity is generally considered as
reflection of well conserved function of in
vitro cell culture systems [27]. Therefore,
at culture day 3 and 8 the rat hepatocyte
cultures were also analyzed after 24 h of
incubation in the presence of the inductor
rifampicin (see Fig. 4 and data not
shown). In the cultures without cryo-
preservation, activities generating
all OHT metabolites except 6a-OHT
and 16a-OHT were induced (induc-
tion � twofold). Interestingly, induction
was observed at day 8 only and was
most pronounced for 6b-OHT and
2b-OHT where fourfold induction was
observed. Notably, induction was also
observed using cultures after cryopreser-
vation and the induction factors achieved
were in the same range (up to fourfold) as
in the fresh cultures although on a lower
level of absolute activity values.
Discussion
As reported in the section ‘‘Results’’, the
fully automated ‘‘on-line’’ SPE-tandem
column-switching RP-HPLC method
with tandem MS-MS detection using an
APCI source in the SRM mode previ-
ously developed for 6b-OHT [1] was
successfully transferred to the quantita-
tive determination of 2a-, 2b-, 6a-, 6b-,7a- and 16a-OHT in cultured hepato-
cytes of mammalian species. The proce-
dure described in more detail in [1] was
the first technique which guarantees that
no ghost-peaks appeared in the chro-
matogram, which means that memory
effects can be completely avoided, as
demonstrated in Fig. 3. It is effected by
cleaning the second SPE column for
sample enrichment as well as the second
analytical column while analytical sepa-
ration currently runs on the first one. At
the rentention time of the IS the back-
ground of both hydroxy-testosterone
detection and blank is slightly elevated.
This effect is present in all chromato-
grams. Nevertheless it does not interfere
with quantification of the hydroxy-tes-
tosterone metabolites. The reason for
this effect is attributable to an unspecific
fragmentation of the IS, which is only
visible due to the high concentration of
the IS. That means that the slight ele-
vation of the background is not caused
by a memory effect.
The BioTrap 500 MSTM SPE-column
used for sample enrichment and cleaning
pertains to the class of so-called
0
0
2
4
6
8
10
0
2
4
6
8
10
0
2
4
6
8
10
0
2
4
6
8
10
NL: 1,00E6
m/z= 268,6-269,6 F:
+ p APCI SRM ms2
305,30@29,00 [
267,70-270,70] MS
CYTO 05 12 146
NL: 1,00E7
m/z= 328,7-329,7 F:
+ p APCI SRM ms2
347,20@29,00 [
327,70-330,70] MS
CYTO 05 12 146
NL: 1,00E6
m/z= 268,6-269,6 F:
+ p APCI SRM ms2
305,30@29,00 [
267,70-270,70] MS
cyto 05 12 148
NL: 1,00E7
m/z= 328,7-329,7 F:
+ p APCI SRM ms2
347,20@29,00 [
327,70-330,70] MS
cyto 05 12 148
Column ARun 146
Column ARun 148
142 6 3810 18
Time (min)
34302622
Fig. 3. A blank chromatogram (column A, run 148) compared to a sample chromatogram(testosterone metabolites after incubation with human hepatocytes as described in the section‘‘Results’’, column A, run 146) is shown. In both cases the scale range is 1.00 · 106. The internalstandards are in the scale range 1.00 · 107
36 Chromatographia 2008, 67, January (No. 1/2) Original
‘‘restricted access materials’’ (RAM-
phases) permitting access to the inner
pore structure only for low molecular
weight molecules while high molecular
weight ones, such as proteins are diverted
to waste [28, 29]. By this measure clog-
ging is extensively avoided and long-term
application guaranteed before replace-
ment of these materials and therefore the
method is excellently suited for metabolic
investigations. In all those studies using
the novel tandem ‘‘on-line’’ SPE tech-
nique it could be shown that indeed no
memory effects occurred. To our
knowledge no tandem SPE/analytical
separation column system as that one
reported in this paper has been published
hitherto. In an analoguous commercially
available system memory effects are only
prevented by the use of a unique SPE
column per sample and use of only a
single separation column. Therefore
possible memory effects are not pre-
vented in the separation column. In our
work however, sample pretreatment is
performed using only a single SPE
column for a large number of samples.
Cleaning of this SPE column as well of
the corresponding separation column is
done using the tandem technique (two
SPE and two separation columns).
Therefore, it is obvious that the benefit
drawn from the novel ‘‘on-line’’ tandem
SPE procedure lies in the fact that both
pre-treatment of a second sample and
column equilibration is done during
separation of the first one which saves
time and money. In this respect it should
be emphasized that numerous analyses
16α Testosterone hydroxylase activity of rat hepatocytes
0
50
100
150
200
250
300
n im/lle
w/lo
mp
n im/lle
w/lo
mp
6β Testosterone hydroxylase activity of rat hepatocytes
0
50
100
150
200
250
300
D 0
Days in culture
a b
2α Testosterone hydroxylase activity of rat hepatocytes
0
50
100
150
200
250
300
2β Testosterone hydroxylase activity of rat hepatocytes
0.00
50.00
100.00
150.00
200.00
250.00
300.00
D 0
Days in culture
nim/lle
w/lo
mp
nim/lle
w/lo
mp
c d
6α Testosterone hydroxylase activity of rat hepatocytes
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.67α Testosterone hydroxylase activity of rat hepatocytes
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
nim/lle
w/lo
mp
fe
D 1 D 3 D 8 D 8 ind
D 0
Days in culture
D 1 D 3 D 8 D 8 ind D 0
Days in culture
D 1 D 3 D 8 D 8 ind
D 0
Days in culture
D 1 D 3 D 8 D 8 ind
without cryopreservationafter cryopreservation
without cryopreservationafter cryopreservation
without cryopreservationafter cryopreservation
without cryopreservationafter cryopreservation
D 8 indD 8D 3D 1
D 0
Days in culture
D 1 D 3 D 8 D 8 ind
without cryopreservationafter cryopreservation
without cryopreservationafter cryopreservation
n im/lle
w/lo
mp
Fig. 4. Testosterone hydroxylation activities generating 2a-OHT (a), 2b-OHT (b), 6a-OHT (c), 6b-OHT (d), 7a-OHT (e) and 16a-OHT (f),respectively, as determined from the supernatant of rat hepatocyte cultures with and without cryopreservation and, for samples from day 8, withand without rifampicin induction (induction, dotted colums). Cell seeding was adjusted such that nearly confluent cultures resulted in 6-well-platesin both fresh and cryopreserved cultures. However, the activities are not normalized to cell numbers. Note that the scale differs between 4a–d and4e–f
Original Chromatographia 2008, 67, January (No. 1/2) 37
can be done on the SPE columns before
they have to be replaced whereas in
contrast, every sample needs a new SPE
cartridge applying the aforementioned
automated technique, which results in
additional analysis costs. Another
advantage of the new ‘‘on-line’’ SPE
procedure is given by a high degree of
reproducibility because a lot of pipetting
steps each contributing to individual
errors are replaced by the fully auto-
mated procedure. Last but not least
handling of problematic samples, i. e.,
those being susceptible to oxidative or
light-induced decomposition as well as
light-induced isomerism is markedly re-
duced because sample pretreatment takes
place in the dark in a closed system.
With respect to application of this
procedure to measurement of biological
samples, quantitation of the six testos-
terone metabolites allows for either
investigation of different culture condi-
tions or donor characterization and can
also be used as an early quality control
assessment, e.g., by measuring the
induction of enzyme activities at day 3.
The method was used for culture super-
natant from rat and human hepatocytes.
The data obtained from human hepato-
cyte preparations have been reported
and discussed earlier [29] and therefore
are not further mentioned here. The
measurements from rat hepatocyte cul-
ture supernatant were equally successful
in specific detection and quantification
of 2a-, 2b-, 6a-, 6b-, 7a- and 16a-OHT
indicating basal levels of the respective
testosterone hydroxylation activities.
Moreover, incubation of the rat hepa-
tocytes in the presence of rifampicin led
to induction of the OHT activities, most
pronounced for 6b-OHT and 2b-OHT
(see Fig. 4).
We have used the sandwich model
[30] as the basis of our cryopreservation
protocol and obtained rat and human
hepatocyte cultures that were viable and
metabolically active at least until day 3
after thawing. All testosterone metabo-
lism activities found in the fresh cultures
were reflected in the cryopreserved
counterparts, including induction (see
Fig. 4). While the absolute activities
were well conserved in rat cultures, the
level was generally reduced in human
hepatocytes [30]. Since the inducibility of
CYP activities is generally considered as
reflection of well conserved function of
in vitro cell culture systems [31], it is of
note that the induction factors achieved
after cryopreservation were in the same
range (up to fourfold) as in the fresh
cultures.
In both rat and human cultures, in-
creased formation of 2a-, 2b-, 6b-, 7a-and 16a-OHT after rifampicin treat-
ment was observed while 6a-OHT gen-
erating activities obviously were not
induced. Other authors have reported
more complex observations, e.g., a
marked increase in cytochrome P 450
oxidase activity occuring after treatment
of rats with, e.g., phenobarbital, 3-
methylcholanthrene and Aroclor 1254,
while 6b-OHT formation decreases but
nevertheless it still remains the principal
testosterone metabolite [14]. A similar
influence of phenobarbital, 3-methyl-
cholanthrene and other kinds of
inducers, such as pregnenolone-16-car-
bonitrile (PCN), dexamethasone, eryth-
romycin estolate, troleandromycin and
spironolactone was reported by
Sonderfan et al. [32]. Due to interac-
tions within the CYP 450 family, inte-
gration of induction and inhibition
phenomena can occur resulting in
complex metabolic patterns. Therefore,
analysis of the six testosterone hydroxy
metabolites as reported in this study
can be used as an indicator system
when hepatocytes are incubated with
known and unknown substances. In this
respect quantification of testosterone
hydroxy metabolites by automated ‘‘on-
line’’ SPE/RP-HPLC can be very useful
for the attribution of induction profiles
to well characterized inducers such as
rifampicin, but also to so far unchar-
acterized substances, e.g., in preclinical
drug development. In addition, the
technology is also suitable for analysis
of hepatocyte-specific metabolic com-
petence when tracking stem cell differ-
entiation towards the hepatocyte
phenotype.
Conclusions
Analysis of the six testosterone hydroxy
metabolites as reported in this study can
be used as an indicator system when
hepatocytes are incubated with known
and unknown substances using quanti-
fication of the resulting testosterone hy-
droxy metabolites by automated ‘‘on-
line’’ SPE/RP-HPLC. The previously
published ‘‘on-line’’ tandem SPE/LC-
MS-MS method for quantitative deter-
mination of 6b-hydroxytestosterone(6b-OHT) [1] could be successfully
extended to measurement of another
five testosterone metabolites, namely
2a-OHT, 2b-OHT, 6a-OHT, 7a-OHT
and 16a-OHT in common with 6b-OHT.
All six metabolites could be well sepa-
rated from each other and quantified
with high sensitivity being sufficient for
quantitation of them in biological fluids,
i. e., in supernatants of cultured human
and rat hepatocytes. The fully auto-
mated sample preparation procedure
tremendously reduces both carryover
effects and possible sample degradation
during processing. In addition, due to
minimization of pipetting steps repro-
ducibility of analytical information is
markedy enhanced allowing processing
of large sample numbers with a mini-
mum of man power. Last but not least it
could be shown that cryopreservation is
a suitable means to preserve hepatocytes
for biopharmaceutical and metabolic
studies and that induction proves to be
an important indicator for preserved
functionality of hepatocytes also after
cryopreservation.
References
1. Friedrich G, Rose T, Rissler K (2003)J Chromotogr B 784:49
2. Engman HE, Lennerhas H, TaipalensuuJ, Otter C, Leidvik B, Artursson P (2001)J Pharm Sci 90:1736
3. Thomas PE, Reik LM, Ryan DE, LevinW (1981) J Biol Chem 256:1044
4. Ryan DE, Thomas PE, Reik LM, LevinW (1982) Xenobiotica 12:727
5. Guengerich FP, Martin MV, Beaune PH,Kremers P, Wolff T, Waxman DJ (1986)J Biol Chem 261:5051
6. Waxman DJ, Attisano C, Guengerich FP,Lapenson DP (1988) Arch Biochem Bio-phys 263:424
7. Guengerich FP, Shimada T (1991) ChemRes Toxicol 4:391
8. Nelson DR, Koymanns L, Kamataki T,Stegemann JJ, Feyereisen R, Waxman DJ,Waterman MR, Gotoh O, Coon MJ, Es-tabrook RW, Gunsalus IC, Nebert DW(1996) Pharmacogenetics 6:1
38 Chromatographia 2008, 67, January (No. 1/2) Original
9. Waxman DJ, Ko A, Walsh C (1983) J BiolChem 258:11937
10. Levin W, Thomas PE, Ryan DE, WoodAW (1987) Arch Biochem Biophys258:630
11. Waxman DJ (1988) Biochem Pharmacol37:71
12. van der Hoven T (1981) Biochem BiophysRes Comm 100:1285
13. Wood AW, Ryan DE, Thomas PE, LevinW (1983) J Biol Chem 258:8839
14. Kern A, Bader A, Pichlmayr R, SewingK-F (1997) Biochem Pharmacol 54:761
15. Gebhard R, Hengstler JG, Muller D,Glockner R, Buenning P, Laube B, Sch-melzer E, Ullrich M, Utesch D, Hewitt N,Ringel M, Reder-Hilz B, Bader A, Lang-sch A, Koose T, Burger HJ, Maas J,Oesch F (2003) Drug Metab Rev 35:145
16. Pelkonen O, Maenpaa J, Taavitsainen P,Rautio A, Raunio H (1988) Xenobiotica28:1203
17. Arlotto MP, Trant JM, Estabrook RW(1991) Methods Enzymol 206:454
18. Smith SJ, Korzewka KR, Aoyama T,Gonzalez FJ, Darbyshire JF, SugiyamaK, Gillette JR (1992) Drug Metabol Dis-pos 20:566
19. Woertelboer HM, de Kruif CA, van IerselAAJ, Falke HE, Noordhoek J, BlaauboerBJ (1990) Biochem Pharmacol 40:2525
20. Hengstler JG, Ringel M, Biefang K,Hammel S, Milbert U, Gerl M, KlebachM, Diener B, Platt KL, Bottger T, Stein-berg P, Oesch F (2000) Chem Biol Interact125:51
21. Ringel M, Oesch F, Gerl M, Klebach M,Quint M, Bader A, Bottger T, HengstlerJG (2002) Xenobiotica 21:653
22. Chung WG, Roh HK, Kim HM, Cha YN(1998) Chem Biol Interact 113:1
23. Bullock P, Pearce R, Draper A, Povdal J,Bracken W, Veltman J, Thomas P, Par-kinson A (1995) Drug Metabol Dispos23:736
24. Parkinson A, Clement RP, Casciano CN,Cayen MN (1992) Biochem Pharmacol43:2169
25. Hengstler JG, Utesch D, Steinberg P,Platt KL, Diener B, Ringel M, Swales N,Fischer T, Biefang K, Gerl M, Bottger T,Oesch F (2000) Drug Metab Rev 32:81
26. Reese JA, Byard JL (1981) In Vitro 17:93527. Li AP, Gorycki PD, Hengstler JG, Ked-
deris GL, Koebe HG, Rahmani R, deSousas G, Silva JM, Skett P (1999) ChemBiol Interact 121:117
28. Cassian NM, Lima VV, Oliveira RV, dePietro AC, Cass QB (2006) Anal BioanalChem 384:1462
29. Souverain S, Rudaz S, Veuthey J-L (2004)J Chromatogr B 801:141
30. Kafert-Kasting S, Alexandrova K, Bart-hold M, Laube B, Friedrich G, ArseniewL, Hengstler JG (2006) Toxicology220:117
31. Dunn JCY, Yarmush ML, Koebe HG,Tompkins RG (1989) FASEB J 3:174
32. Sonderfan AJ, Arlotto MP, Dutton D,McMillen SK, Parkinson A (1987) ArchBiochem Biophys 255:27
Original Chromatographia 2008, 67, January (No. 1/2) 39